[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368833-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368833-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","limk2-promotes-centrosome-clustering-and-cancer-progression-by-activating-mst4-mediated-phosphorylation-of-npm1","LIMK2 promotes centrosome clustering and cancer progression by activating MST4-mediated phosphorylation of NPM1","","LIMK2 drives centrosome clustering and cancer progression by activating MST4-mediated phosphorylation of NPM1. Centrosome amplification supports cancer cell survival by enabling clustered extra centrosomes for bipolar mitosis, yet the regulatory pathway remains unclear. The study shows LIMK2 phosphorylates MST4 at threonine 178, which then binds and phosphorylates NPM1 at T95, essential for clustering and proliferation. NPM1 depletion disrupts clustering and suppresses malignant growth, while LIMK2 knockout or inhibition attenuates tumorigenesis and induces multipolar spindle assembly and apoptosis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/limk2-promotes-centrosome-clustering-and-cancer-progression-by-activating-mst4-mediated-phosphorylation-of-npm1/368833/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/limk2-promotes-centrosome-clustering-and-cancer-progression-by-activating-mst4-mediated-phosphorylation-of-npm1/368833.png","ImageObject",300,407,{"name":42,"@type":43},"4398046744996","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What signaling pathway does the study identify as controlling centrosome clustering?","Question",{"text":63,"@type":64},"The study identifies the LIMK2/MST4/NPM1 signaling pathway, where LIMK2 activates MST4 and MST4 phosphorylates NPM1 at T95 to promote centrosome clustering.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Why is NPM1 phosphorylation at T95 important?",{"text":68,"@type":64},"Phosphorylation of NPM1 at T95 is described as essential for centrosome clustering and tumor cell proliferation, and genetic depletion of NPM1 disrupts clustering and suppresses malignant growth.",{"name":70,"@type":61,"acceptedAnswer":71},"How does targeting LIMK2 affect cancer progression in vivo and in therapeutic settings?",{"text":72,"@type":64},"LIMK2 knockout significantly attenuates 4NQO-induced esophageal tumorigenesis in murine models. shRNA knockdown or pharmacological inhibition (CRT0105950) suppresses centrosome clustering, prevents pseudo-bipolar spindle formation, induces mitosis arrest, promotes multipolar spindle assembly, and triggers apoptotic cell death.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368833,1790203198,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":11,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":133,"file_id":134,"file_url":135,"file_type":136,"file_size":137,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":138,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},4398046744996,"Oncogene [www.nature.com/onc](www.nature.com/onc)  \nARTICLE OPEN   \nLIMK2 promotes centrosome clustering and cancer progression by activating MST4-mediated phosphorylation of NPM1  \nJie Tian 1,2, Shihui Liu 1, Yunqing Zhang 1, Huajie Jia 1, Wenna Nie2, Ran Yang2, Mengmeng Ge2, Kangdong Liu  Mengqiu Song 1,2,3,4 ✉ and Zigang Dong 1,2,3,4,6 ✉  \n1,2,3,4,5,6  \n,  \n© The Author(s) 2025  \n\n|  | Centrosome ampliﬁcation, a hallmark of diverse malignancies, enables cancer cell survival through centrosome clustering during mitosis, presenting a promising therapeutic target for selective elimination of cancer cells with supernumerary centrosomes. While the regulatory mechanisms underlying centrosome clustering remain poorly understood, our study identiﬁes LIM kinase 2 (LIMK2) as a critical regulator of this process, demonstrating cancer correlation with tumor progression. Mechanistically, LIMK2 phosphorylates mammalian sterile-20-like kinase 4 (MST4) at threonine 178 (T178), activating its kinase function. Activated MST4 subsequently binds and phosphorylates nucleophosmin 1 (NPM1) at T95, a modiﬁcation essential for centrosome clustering and tumor cell proliferation. Genetic depletion of NPM1 disrupts centrosome clustering and suppresses malignant growth. In vivo studies revealed that LIMK2 knockout signiﬁcantly attenuates 4-nitroquinoline-1-oxide (4NQO) induced esophageal tumorigenesis in murine models. Therapeutic targeting of LIMK2 through shRNA-mediated knock down or pharmacological inhibition (CRT0105950) suppresses centrosome clustering by preventing “pseudo-bipolar” spindle formation, inducing mitosis arrest. This centrosome de-clustering promotes multipolar spindle assembly, ultimately triggering apoptotic cell death. Notably, CRT0105950 treatment effectively suppressed cell-derived xenograft tumor growth. Our ﬁndings elucidate the pivotal role of the LIMK2/MST4/ |  |\n| --- | --- | --- |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| NPM1 pathway in cancer progression and establish a novel therapeutic paradigm for broad-spectrum anticancer intervention. |  |  |\n|  | Oncogene (2025) 44:3625–3639; [https://doi.org/10.1038/s41388-025-03518-6](https://doi.org/10.1038/s41388-025-03518-6) |  |\n|  |  |  |\n\nINTRODUCTION  \nCentrosome ampliﬁcation is a hallmark of cancer, associated with aggressive disease and poorer clinical outcomes [1–3] . Causes of centrosome ampliﬁcation include cell–cell fusion [4], cytokinesis failure, centrosome overduplication [5], centrosome fragmentation, and mitotic slippage [6, 7] . Such ampliﬁcation leads to abnormal chromosome segregation during mitosis, driving chromosome instability, aneuploidy, tumor progression, metastasis, and poor prognosis [1, 8–10] . Despite these challenges, cancer cells mitigate lethal consequences by clustering extra centrosomes into two poles to enable bipolar mitosis [11, 12] . However, the molecular mechanisms underlying centrosome clustering remain unclear, making it critical to elucidate these processes for the development of targeted cancer therapies.  \nLIM domain kinase 2 (LIMK2) is a serine/threonine kinase regulates actin ﬁlament dynamics and plays a critical role in the growth and invasion of castration-resistant prostate cancer (CRPC)[13–16], triple-negative breast cancer (TNBC) [17], lung squamous cell carcinoma (LUSC) [18], and glioblastoma (GBM) [19] . To date, NK3 homeobox 1 (NKX3.1) [14], coﬁlin [20], membrane type 1 matrix metalloproteinase (MT1-MMP) [21], Twist-related protein 1 (TWIST1) [15] and phosphatase and tensin homolog (PTEN) [16]  \nare the only known substrates of LIMK2 . However, its role in centrosome ampliﬁcation and clustering has not been well studied.  \nNPM1 is a nucleolar phosphoprotein involved in proliferation, apoptosis, ribosome assembly, and centrosome duplication [22] . Phosphorylation at speciﬁc sites regulates its function, with recent studies showed tha","cbCaiiOrLTTn1eWn","https://ap.wps.com/l/cbCaiiOrLTTn1eWn","pdf",7816696,15,"English","# Introduction\n## Centrosome amplification and cancer outcomes\n## LIMK2 substrates and knowledge gap\n## NPM1 regulation and unknown kinase for T95\n## Study aims: LIMK2/MST4/NPM1 signaling in clustering","[{\"question\":\"What signaling pathway does the study identify as controlling centrosome clustering?\",\"answer\":\"The study identifies the LIMK2/MST4/NPM1 signaling pathway, where LIMK2 activates MST4 and MST4 phosphorylates NPM1 at T95 to promote centrosome clustering.\"},{\"question\":\"Why is NPM1 phosphorylation at T95 important?\",\"answer\":\"Phosphorylation of NPM1 at T95 is described as essential for centrosome clustering and tumor cell proliferation, and genetic depletion of NPM1 disrupts clustering and suppresses malignant growth.\"},{\"question\":\"How does targeting LIMK2 affect cancer progression in vivo and in therapeutic settings?\",\"answer\":\"LIMK2 knockout significantly attenuates 4NQO-induced esophageal tumorigenesis in murine models. shRNA knockdown or pharmacological inhibition (CRT0105950) suppresses centrosome clustering, prevents pseudo-bipolar spindle formation, induces mitosis arrest, promotes multipolar spindle assembly, and triggers apoptotic cell death.\"}]","LIMK2 promotes centrosome clustering and cancer progression by activating MST4-mediated phosphorylation of NPM1 | PDF",1790178871,38,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a30586be0fefedaa1dcc2b5209ea0d11.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6698bd1101e6791d590697e3d141383c.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d31e3e2784dc2fe7b2d876928d102acf.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d92f9adef0f6c60e83aff2461a4a152.webp",980,1301]